• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

iScience . Genomic diversity of SARS-CoV-2 can be accelerated by mutations in the nsp14 gene

tetano

Editor, Senior Moderator
iScience


. 2023 Feb 16;106210.
doi: 10.1016/j.isci.2023.106210. Online ahead of print.
Genomic diversity of SARS-CoV-2 can be accelerated by mutations in the nsp14 gene


Kosuke Takada[SUP] 1 2 [/SUP], Mahoko Takahashi Ueda[SUP] 3 [/SUP], Shintaro Shichinohe[SUP] 1 [/SUP], Yurie Kida[SUP] 1 [/SUP], Chikako Ono[SUP] 4 5 [/SUP], Yoshiharu Matsuura[SUP] 4 5 [/SUP], Tokiko Watanabe[SUP] 1 5 6 [/SUP], So Nakagawa[SUP] 2 7 [/SUP]



Affiliations

Abstract

Coronaviruses, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), encode a proofreading exonuclease, nonstructural protein 14 (nsp14), that helps ensure replication competence at a low evolutionary rate compared with other RNA viruses. In the current pandemic, SARS-CoV-2 has accumulated diverse genomic mutations including in nsp14. Here, to clarify whether amino acid substitutions in nsp14 affect the genomic diversity and evolution of SARS-CoV-2, we searched for amino acid substitutions in nature that may interfere with nsp14 function. We found that viruses carrying a proline-to-leucine change at position 203 (P203L) have a high evolutionary rate and that a recombinant SARS-CoV-2 virus with the P203L mutation acquired more diverse genomic mutations than wild-type virus during its replication in hamsters. Our findings suggest that substitutions, such as P203L, in nsp14 may accelerate the genomic diversity of SARS-CoV-2, contributing to virus evolution during the pandemic.

Keywords: SARS-CoV-2; coronavirus; mutation; non-structural protein 14.
 
Back
Top Bottom